BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Malakoti F, Targhazeh N, Abadifard E, Zarezadeh R, Samemaleki S, Asemi Z, Younesi S, Mohammadnejad R, Hadi Hossini S, Karimian A, Alemi F, Yousefi B. DNA repair and damage pathways in mesothelioma development and therapy. Cancer Cell Int 2022;22:176. [PMID: 35501851 DOI: 10.1186/s12935-022-02597-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Gesmundo I, Pedrolli F, Vitale N, Bertoldo A, Orlando G, Banfi D, Granato G, Kasarla R, Balzola F, Deaglio S, Cai R, Sha W, Papotti M, Ghigo E, Schally AV, Granata R. Antagonist of Growth Hormone-Releasing Hormone Potentiates the Antitumor Effect of Pemetrexed and Cisplatin in Pleural Mesothelioma. IJMS 2022;23:11248. [DOI: 10.3390/ijms231911248] [Reference Citation Analysis]
2 Røe OD, Creaney J; BAP1 Study Group. Response to "Revisiting 'BAP1ness' in Malignant Pleural Mesothelioma". J Thorac Oncol 2022;17:e69-70. [PMID: 35931425 DOI: 10.1016/j.jtho.2022.05.013] [Reference Citation Analysis]